Biocytogen Company Overview – Introductory Brochure
Powered by cutting-edge gene editing technologies and a state-of-the-art animal facility, we have developed an integrated platform for preclinical antibody drug discovery, which includes animal and cell model generation, therapeutic antibody discovery (via RenMabTM, RenLite®, RenNano® mice), and in vivo/in vitro pharmacological studies.
With facilities in both the US and China, our CRO division has enabled global partnerships with numerous academic and industrial clients to accelerate basic and preclinical research by offering the following products and services:
- Gene Targeting
- Antibody Discovery
- Pharmacology Services
- Off-the-shelf Models
